Amalgamated Bank’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-345
Closed -$7K 2869
2025
Q4
$7K Sell
345
-30
-8% -$557 ﹤0.01% 2612
2025
Q3
$6K Hold
375
﹤0.01% 2725
2025
Q2
$7K Buy
+375
New +$7.6K ﹤0.01% 2615
2022
Q2
Sell
-380
Closed -$6K 3229
2022
Q1
$6K Buy
+380
New +$7.85K ﹤0.01% 3021

Other funds holding TECX

Amalgamated Bank's TECX Position: Q1 2026 in Review

Amalgamated Bank sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 345 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in TECX in Q1 2022 and held it in 4 quarters. The position peaked at $7K in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Amalgamated Bank reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 345 Tectonic Therapeutic shares in Q1 2026, an estimated $7K.
  • Amalgamated Bank first reported a position in Tectonic Therapeutic in Q1 2022 and held it in 4 quarters.
  • Amalgamated Bank's Tectonic Therapeutic position peaked at $7K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.